Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

75 results
Display

Survivin may be a Key Target for Oxaliplatin

Baek MJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of FOLFIRI as Second-line Chemotherapy in Advanced Gastric Cancer

Park SC, Chun HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients

Lee M

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy

Seo AN, Kim H

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
FOLFOX-4 Combination Chemotherapy as a First-line Treatment in Patients with Advanced Gastric Cancer

Song HS

  • KMID: 2264195
  • Korean J Med.
  • 2012 Jan;82(1):35-36.
The FOLFOX-4 regimen as first-line treatment in patients with advanced gastric cancer has not evidence of category 1 for prolongation of survival in patients with advanced gastric cancer. Therefore, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple Cancers in a Patient with Systemic Sclerosis and Aggravated Interstitial Lung Disease by Chemotherapy

Park CK, Lee SJ, Cho HJ, Lee KS, Kim SJ, Cho GM, Lee HN

  • KMID: 2320448
  • Tuberc Respir Dis.
  • 2013 Sep;75(3):111-115.
Although the relationship between malignancy risk with systemic sclerosis (SSc) has been inconclusive, there are some previous studies for a positive correlation. Most patients with SSc have some degree of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oxaliplatin-induced Pulmonary Fibrosis: Two Case Reports

Ryu CG, Jung EJ, Kim G, Kim SR, Hwang DY

Oxaliplatin with infusional 5-fluorouracil plus leucovorin (FOLFOX regimen) is the one of the standard chemotherapy regimens for treating a colorectal carcinoma. The most common side effects include neutropenia, diarrhea, vomiting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adjuvant Chemotherapy in Colon Cancer

Cho SH

  • KMID: 2263448
  • Korean J Med.
  • 2012 Sep;83(3):297-304.
Colorectal cancer represents a major public health problem in worldwide including Korea. According to the National Cancer Registry, colon cancer is the third most common cancer and the forth leading...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices

Park SC, Chun HJ

  • KMID: 1806634
  • Gut Liver.
  • 2013 Jul;7(4):385-393.
No standard adjuvant or palliative chemotherapy regimen has been internationally approved for patients with advanced gastric cancer. Adjuvant chemoradiotherapy is administered prior to surgery and is used in the Unitied...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgical Management of Colorectal Cancer

Jeong SY

In Korea, the incidence of colorectal cancer has rapidly increased in both men and women during recent two decades, and now it is the third most common cancer. Deaths related...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Autoimmune Hemolytic Anemia Caused by Repeated Administration of Oxaliplatin

Kim DE, Cho DH, Rew SY, Hwang JE, Bae WK, Shim HJ, Chung IJ

Oxaliplatin is widely used as a chemotherapeutic agent for treating unresectable or metastatic gastrointestinal tract cancer, such as gastric cancer and colorectal cancer. The toxic effects commonly associated with oxaliplatin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple Hepatic and Paraaortic Lymph Nodes Metastases from Advanced Gastric Cancer Successfully Treated with Oxaliplatin/Leucovorin/5-FU

Cho JN, Kim YH

  • KMID: 2211233
  • J Korean Surg Soc.
  • 2008 Aug;75(2):134-138.
The treatment for the hepatic and lymph nodes metastases after curative resection of gastric cancer has not yet been established. The different kinds of treatment that have been attempted have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemotherapy of Advanced Gastric Cancer

Jung JT

Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric cancer, combination chemotherapy improves overall survival compared with best supportive care alone. However, there is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in the treatment of patients with colorectal liver metastases

Nam EM

  • KMID: 2259112
  • Korean J Med.
  • 2010 Aug;79(2):125-132.
Colorectal cancer (CRC) is 2nd to 3rd common cancer and the annual incidence of CRC is increasing in Korea. The liver is the most frequent metastatic site of colorectal cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Successful Allogeneic Stem Cell Transplantation for Chemotherapy-refractory Hepatosplenic gamma delta-T Cell Lymphoma

Kim SB, Jeong SH, Park JH, Kim HS, Kim BK, Lee HS

Hepatosplenic T-cell lymphoma is a rare histologic type of peripheral T-cell lymphoma, which is characterized clinically by predominant involvement of the liver and spleen, with little or no adenopathy, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells

Sohn WJ, Lee JW, Park DG

PURPOSE: Oxaliplatin is a third-generation platinum compound, and it has no nephrotoxicity and has reduced bone marrow toxicity. Cancer cells that are resistant to cisplatin are sensitive to oxaliplatin. Oxaliplatin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intestinal Perforation in Colorectal Cancers Treated with Bevacizumab (Avastin(R))

Choi YI, Lee SH, Ahn BK, Baek SU, Park SJ, Kim YS, Shin SH

  • KMID: 2166016
  • Cancer Res Treat.
  • 2008 Mar;40(1):33-35.
Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), and it has shown promise as a clinical agent against metastatic colorectal cancer, and particularly in combination with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transcatheter Arterial Chemotherapy with Miriplatin for Hepatocellular Carcinoma Patients with Chronic Renal Failure: Report of Three Cases

Imai N, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H

  • KMID: 2135078
  • Gut Liver.
  • 2013 Mar;7(2):246-251.
Miriplatin is a novel lipophilic platinum complex that was developed to treat hepatocellular carcinoma (HCC). Although HCC patients frequently have coexisting chronic renal failure, little prospective data are available regarding...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Advanced Gastric Cancer Presenting as Multiple Colonic Lymphoid Hyperplasia

Lee IH, Lee J, Byeon SW, Lee H, Huo S, Yoon SB, Kim JS, Lee SH, Roh SY

Gastric cancer frequently disseminates to the liver, lung, and bone via hematogeneous, lymphatic, or peritoneal routes. However, gastric adenocarcinoma that metastasize to the colon and that shows typical linea platisca...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer

Oh PJ, Lee JR

PURPOSE: The purpose of this study was to test a hypothetical model of chemotherapy-related cognitive impairment (CRCI) and depression in people with gastrointestinal cancer. METHODS: A purposive sample of 198 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr